Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis

• Published in: BMC medicine Vol. 20; no. 1; pp. 444 - 10
• Main Authors: Zhang, Ting, Mei, Qimin, Zhang, Zhaocai, Walline, Joseph Harold, Liu, Yecheng, Zhu, Huadong, Zhang, Shuyang
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 15.11.2022; BioMed Central; BMC
• Subjects: Adult; Bias; Cohort analysis; Cohort Studies; Complications; Coronaviruses; COVID-19; COVID-19 - diagnosis; COVID-19 - epidemiology; Diabetes; Diabetes mellitus; Diabetes mellitus (insulin dependent); Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - diagnosis; Diabetes Mellitus, Type 2 - epidemiology; Diagnosis; Female; Health risks; Humans; Infections; Male; Medical diagnosis; Meta-analysis; Mortality; Respiratory diseases; Respiratory tract; Respiratory tract diseases; Respiratory Tract Infections; Risk assessment; Risk factors; SARS-CoV-2; SARS-CoV-2 virus; Severe acute respiratory syndrome coronavirus 2; Statistical analysis; Systematic review; Unmeasured confounders; Viral diseases; Young Adult; China; COVID-19; Diabetes mellitus; SARS-CoV-2 virus; Unmeasured confounders

There is growing evidence that patients recovering after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may have a variety of acute sequelae including newly diagnosed diabetes. However, the risk of diabetes in the post-acute phase is unclear. To solve this question, we aime...